Towa Pharmaceutical Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TWAPF research report →
About the company
Operating in Japan, Towa Pharmaceutical Co. , Ltd. and its subsidiaries are engaged in the research, development, production, and sale of prescription drugs, active pharmaceutical ingredients, and intermediates.
- CEO
- Itsuro Yoshida
- IPO
- 2009
- Employees
- 4,588
- HQ
- Osaka, JP
Price Chart
- Market Cap
- $828.51M
- P/E
- 36.80
- P/S
- 0.71
- P/B
- 1.08
- EV/EBITDA
- 9.79
- Div Yield
- 2.04%
- Gross Margin
- 36.21%
- Op Margin
- 8.44%
- Net Margin
- 1.92%
- ROE
- 2.92%
- ROIC
- 2.25%
- Revenue
- $275.43B · 6.10%
- Net Income
- $5.28B · -72.17%
- EPS
- $107.05 · -72.25%
- Op Income
- $23.25B
- FCF YoY
- 204.87%
- 52W High
- $25.33
- 52W Low
- $16.83
- 50D MA
- $16.83
- 200D MA
- $16.83
- Beta
- -0.09
- Avg Volume
- 116
Get TickerSpark's AI analysis on TWAPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our TWAPF coverage
Recent articles, reports, and earnings notes.
No research on TWAPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TWAPF report →Similar companies
Peers in the same neighborhood.